{
  "retracted": true,
  "timestamp": 1454371200000,
  "updates": [
    {
      "timestamp": 1585027244996,
      "identifier": {
        "doi": "10.1007/s11095-016-1866-8"
      },
      "type": "retraction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s11095-015-1625-2"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Retraction Note: RGD peptide-pegylated PLLA nanoparticles containing epirubicin hydrochloride exhibit receptor-dependent tumor trafficking in vitro and in vivo"
}
